ImmunityBio Inc (IBRX)
8.12
+0.06
(+0.74%)
USD |
NASDAQ |
May 10, 16:00
8.11
-0.01
(-0.12%)
After-Hours: 05:35
ImmunityBio Total Assets (Quarterly): 504.45M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 504.45M |
| September 30, 2023 | 432.42M |
| June 30, 2023 | 291.23M |
| March 31, 2023 | 343.40M |
| December 31, 2022 | 362.36M |
| September 30, 2022 | 352.94M |
| June 30, 2022 | 317.72M |
| Date | Value |
|---|---|
| March 31, 2022 | 389.59M |
| December 31, 2021 | 468.91M |
| September 30, 2021 | 214.42M |
| June 30, 2021 | 246.30M |
| March 31, 2021 | 209.43M |
| December 31, 2020 | 221.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
209.43M
Minimum
Mar 2021
504.45M
Maximum
Dec 2023
334.96M
Average
343.40M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | 648.44M |
| iBio Inc | 34.02M |
| Lixte Biotechnology Holdings Inc | 4.309M |
| Abeona Therapeutics Inc | 64.00M |
| Chromocell Therapeutics Corp | 0.0228M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.090B |
| Shareholders Equity (Quarterly) | -586.99M |
| Debt to Equity Ratio | -1.161 |
| Current Ratio | 5.046 |
| Net Debt Paydown Yield | -0.12% |